Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks
暂无分享,去创建一个
K. White | P. Sax | A. Zolopa | J. Gallant | C. Cohen | D. Wohl | B. Kearney | A. Cheng | Lijie Zhong | E. Dejesus | E. Quirk | A. Mills | Kitty Yale | J. Szwarcberg | Hui C Liu